Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1β-driven model of joint pathology
Authors:
- I. ScottISI. Scott
- U. RashidURU. Rashid
- S. BallSBS. Ball
- 1 June 2009
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 17 (6) , 790-797
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 5 REVERSIBLE MRI FEATURES AND KNEE PAIN FLUCTUATION: THE MOST STUDYOsteoarthritis and Cartilage, 2007
- Cytokine Targeting in OsteoarthritisCurrent Drug Targets, 2007
- Radiosynoviorthesis in Osteoarthritis and Other Disorders with Concomitant Synovitis in Comparison to Rheumatoid ArthritisCancer Biotherapy and Radiopharmaceuticals, 2005
- Osteoarthritis — an untreatable disease?Nature Reviews Drug Discovery, 2005
- Suppression of early experimental osteoarthritis by gene transfer of interleukin‐1 receptor antagonist and interleukin‐10Journal of Orthopaedic Research, 2004
- Osteoarthritis: symptoms, signs and source of painInflammopharmacology, 2004
- An update on the pathogenesis and epidemiology of osteoarthritisRadiologic Clinics of North America, 2004
- Pralnacasan, an inhibitor of interleukin-1β converting enzyme, reduces joint damage in two murine models of osteoarthritisOsteoarthritis and Cartilage, 2003
- The bone and joint decade: A catalyst for progressArthritis & Rheumatism, 2001
- Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targetsArthritis & Rheumatism, 2001